Document is current
Any future updates will be listed below
-
Authors
Naganawa, Mika https://orcid.org/0000-0002-4408-2621
Zheng, Ming-Qiang
Gallezot, Jean-Dominique
Bonomi, Robin
Gu, Jiwei
Gao, Hong
Jacutin-Porte, Swanee
Nabulsi, Nabeel B.
Koole, Michel
Van Laere, Koen
Matuskey, David
Huang, Yiyun
Carson, Richard E.
-
Funding
Funding for this research was provided by:
National Institute of Mental Health (U01MH107803)
- License Information
-
More Information
Article History
Received: 18 February 2025
Accepted: 31 May 2025
First Online: 21 June 2025
Declarations
:
: The Study protocol involving human participants was approved by the Yale Human Investigation Committee, the Yale-New Haven Hospital Radiation Safety Committee, and the Yale University Radiation Safety Committee. Study procedures were performed in accordance with federal guidelines and regulations of the United States for the protection of human research subjects contained in Title 45 Part 46 of the Code of Federal Regulations (45 CFR 46). All subjects signed a written informed consent.
: Not applicable.
: Informed consent was obtained from all individual participants included in the study.
: Jean-Dominique Gallezot has received funding from Intra-Cellular Therapies, Inc. Koen Van Laere obtained speaker fees from GE Healthcare, is advisory board member for Enigma USA and conducted contract research through KU Leuven with BMS, Cerevel, Eikonizo, Janssen Pharmaceutics, Lantheus, Lundbeck and Rapport Therapeutics. The other authors have no relevant financial or non-financial interest to disclose.
